|
|
|
Sunday, March 25, 2007 - 1:30 PM, Elizabeth F
|
- Molecular Profiling in Neoplasia for the Surgical Pathologist
|
|
Moderator:
|
Thomas J. Giordano, University of Michigan, Ann Arbor, MI
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. Mark A. Rubin indicated he has grant/research support from Gen-Probe. Other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to download handout in 1-per-page format for the entire meeting
Click here to download handout in 6-per-page format for the entire meeting
Click any blue title below to display and print the handout for individual lecture(s):
| 1:30 | TMPRSS2: ERG Gene Fusion Provide Insight Into the Heterogeneity of Prostate Cancer - Mark A. Rubin, Brigham & Women's Hospital, Boston, MA |
| 2:15 | Using Sarcoma Gene Expression Profiles to Study Cancer Stroma - Matt van de Rijn, Stanford University Medical Center, Stanford, CA |
| 3:00 | Break |
| 3:30 | Translating Mass Spectrometry - Based Proteomics of Malignant Lymphoma into Clinical Application - Megan S. Lim, University of Michigan, Ann Arbor, MI |
| 4:15 | Molecular Profiles of Well - Differentiated Follicular Cell Thyroid Carcinoma - Thomas J. Giordano, University of Michigan, Ann Arbor, MI |
| The ASIP Education Committee reviewed critiques of past symposia whose objective has been to demonstrate how advances in the understanding of pathogenesis can be applied to surgical pathology practice. The committee felt this should continue to be the focus. Pathologists need new strategies to solve key differential diagnostic problems for tumors. The objective of this program is to demonstrate how advances in the understanding of molecular pathogenesis and diagnostic techniques can lead to better diagnostic and prognostic tests. |
|
|
|
